BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 6239381)

  • 1. The Impact of Short-Term, Intensive Antifolate Treatment (with Pyrimethamine and Sulfadoxine) and Antibiotics Followed by Long-Term, Secondary Antifolate Prophylaxis on the Rate of Toxoplasmic Retinochoroiditis Recurrence.
    Borkowski PK; Brydak-Godowska J; Basiak W; Świtaj K; Żarnowska-Prymek H; Olszyńska-Krowicka M; Kajfasz P; Rabczenko D
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004892. PubMed ID: 27542116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical signatures and new drug targets for gametocytocidal drug development.
    Sun W; Tanaka TQ; Magle CT; Huang W; Southall N; Huang R; Dehdashti SJ; McKew JC; Williamson KC; Zheng W
    Sci Rep; 2014 Jan; 4():3743. PubMed ID: 24434750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Pyrimethamine/Sulfadoxine versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years.
    Zheng W; Jiang H; Xiong Z; Jiang Z; Chen H
    Iran J Parasitol; 2013 Jan; 8(1):1-17. PubMed ID: 23682255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum.
    Monatrakul P; Mungthin M; Dondorp AM; Krudsood S; Udomsangpetch R; Wilairatana P; White NJ; Chotivanich K
    Malar J; 2010 Nov; 9():326. PubMed ID: 21078202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial drugs clear resistant parasites from partially immune hosts.
    Cravo P; Culleton R; Hunt P; Walliker D; Mackinnon MJ
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2897-901. PubMed ID: 11557487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive changes in Plasmodium transmission strategies following chloroquine chemotherapy.
    Buckling AG; Taylor LH; Carlton JM; Read AF
    Proc Biol Sci; 1997 Apr; 264(1381):553-9. PubMed ID: 9149425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifolic combinations in the treatment of malaria.
    Conno L
    Bull World Health Organ; 1974; 50(3-4):223-30. PubMed ID: 4613504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative drug trial of a sulfadoxine/pyrimethamine and a sulfalene/pyrimethamine combination against Plasmodium falciparum infections in semi-immune populations of Burma.
    Tin F; Nyunt-Hlaing
    Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):238-48. PubMed ID: 6239381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of falciparum malaria with sulfalene-pyrimethamine versus sulfadoxine-pyrimethamine.
    Chongsuphajaisiddhi T; Youngchaiyudha S; Rungpitarangsri V; Trishnananda M; Ruksakul T; Charnond L; Boonamrung S
    Southeast Asian J Trop Med Public Health; 1980 Dec; 11(4):524-7. PubMed ID: 7013094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.
    Tin F; Hlaing N; Tun T; Win S; Lasserre R
    Bull World Health Organ; 1985; 63(4):727-30. PubMed ID: 2935320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
    Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
    Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
    Botero D; Restrepo M; Montoya A
    Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.